Page last updated: 2024-11-05

solasulfone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Solasulfone, also known as dapsone, is a sulfone antibiotic used to treat leprosy and other infections. It is synthesized through a multi-step process involving the reaction of aniline with chlorosulfonic acid to form sulfanilic acid, followed by a series of reactions to introduce the sulfone group. Solasulfone exerts its therapeutic effect by inhibiting the synthesis of dihydrofolate reductase, an enzyme essential for bacterial growth. It is particularly effective against Mycobacterium leprae, the causative agent of leprosy. Solasulfone has been studied extensively for its potential applications in treating various infectious diseases, including malaria, toxoplasmosis, and Pneumocystis pneumonia. Its long history of use and effectiveness in treating leprosy make it a valuable therapeutic agent. However, concerns regarding adverse effects, such as hemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency, have prompted researchers to investigate alternative treatment options.'

solasulfone: used in drug therapy of leprosy; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8626
CHEMBL ID2106031
MeSH IDM0054811

Synonyms (29)

Synonym
phenopryldiasulfone sodique
solapsone [dcit]
einecs 205-116-7
solasulfonum [inn-latin]
tetrasodium salt of 1,1'-(sulfonylbis(p-phenylimino))bis-(3-phenyl-1,3-propanedisulfonic acid)
sulfetrone
solasulfona [inn-spanish]
4,4'-diamino-diphenyl-sulfon-di-(3-phenyl-propan-1,3-disulfonat)natrium (1:4) [german]
solasulfone
1,3-propanedisulfonic acid, 1,1'-(sulfonylbis(p-phenyleneimino))bis(3-phenyl-, tetrasodium salt
solasulfone [inn]
133-65-3
phenopryldiasulfone sodium
CHEMBL2106031
solasulphone
unii-h12je4313s
h12je4313s ,
solasulfona
solasulfonum
4,4'-diamino-diphenyl-sulfon-di-(3-phenyl-propan-1,3-disulfonat)natrium (1:4)
solapsone
solapsone [mart.]
solasulfone [mi]
tetrasodium salt of 1,1'-(sulfonylbis(p-phenylimino)bis-(3-phenyl-1,3-propanedisulfonic acid)
solasulfon
DTXSID50927894
tetrasodium;1-phenyl-3-[4-[4-[(3-phenyl-1,3-disulfonatopropyl)amino]phenyl]sulfonylanilino]propane-1,3-disulfonate
Q7557110
sodium 3,3'-((sulfonylbis(4,1-phenylene))bis(azanediyl))bis(1-phenylpropane-1,3-disulfonate)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (93.75)18.7374
1990's1 (3.13)18.2507
2000's1 (3.13)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.55 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]